Home

Jeffrey W. Albers, Director: Kymera Therapeutics KYMR Sell · Filed 25/12/08

Trade details

Type
Insider sale
Amount
$203,355.6
Shares · price
2,252 sh · $90.30 a share
Held after
0 sh
Trade date
25/12/08
Filed
25/12/08
Days to filing
0 days

Sold 100.0% of holdings

Share of holding sold
100.0%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/08~01/07

Jeffrey W. Albers's recent trades

  • Jeffrey W. Albers

    Planned sale10b5-1 planSpyre Therapeutics

    $517.1K

    Filed 08/07

  • Jeffrey W. Albers

    Planned sale10b5-1 planSpyre Therapeutics

    $1.9M

    Filed 08/07

  • Jeffrey W. Albers

    Sell10b5-1 planKymera Therapeutics

    $245.5K

    Filed 25/12/08

  • Jeffrey W. Albers

    Planned sale10b5-1 planKymera Therapeutics

    $333.1K

    Filed 25/12/08

  • Jeffrey W. Albers

    Sell10b5-1 planKymera Therapeutics

    $296K

    Filed 25/10/14

Jeffrey W. Albers, Director — sold $203.4K of Kymera Therapeutics KYMR · 100.0% of holdings · 10b5-1 plan | Whalegun